WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the BIO CEO & Investor Conference to be held February 12-14, 2007 at the Waldorf-Astoria in New York, NY. Alan W. Dunton, M.D., Panacos' Chief Executive Officer, will present a corporate overview on Wednesday, February 14 at 3:00 p.m. In addition, Graham Allaway, Ph.D., Panacos' President and Chief Operating Officer, will participate in an HIV panel discussion on Monday, February 12 at 3:30 p.m. EST.
